Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans.

Front Endocrinol (Lausanne)

Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.

Published: August 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441540PMC
http://dx.doi.org/10.3389/fendo.2023.1253675DOI Listing

Publication Analysis

Top Keywords

editorial fgf21
4
fgf21 therapeutic
4
therapeutic target
4
target obesity
4
obesity insulin
4
insulin resistance
4
resistance rodent
4
rodent models
4
models humans
4
editorial
1

Similar Publications

Myokines: metabolic regulation in obesity and type 2 diabetes.

Life Metab

June 2024

Department of Pathology and Pathophysiology and Department of Cardiology of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Skeletal muscle plays a vital role in the regulation of systemic metabolism, partly through its secretion of endocrine factors which are collectively known as myokines. Altered myokine levels are associated with metabolic diseases, such as type 2 diabetes (T2D). The significance of interorgan crosstalk, particularly through myokines, has emerged as a fundamental aspect of nutrient and energy homeostasis.

View Article and Find Full Text PDF

FGF21 responses to alcohol, an insight from a comparative study in individuals with alcohol use disorder.

Alcohol

February 2025

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA. Electronic address:

View Article and Find Full Text PDF

Editorial: Role of mitochondrial stress response in metabolic health.

Front Endocrinol (Lausanne)

October 2024

Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.

View Article and Find Full Text PDF

Unlabelled: The article has been withdrawn at the request of the author. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.

View Article and Find Full Text PDF

Background: Carotid endarterectomy (CEA) for the prevention of upcoming vascular and cerebral events is necessary in patients with high-grade stenosis (≥70%). In the framework of the Italian National project Age.It, a pilot study was proposed aiming at the discovery of a molecular signature with predictive potential of carotid stenosis comparing 65+ asymptomatic and symptomatic inpatients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!